Roxadustat enhances inflammation and metabolic reprogramming in human leukocytes by affecting oxygen sensing
J Immunol. 2025 Aug 12:vkaf167. doi: 10.1093/jimmun/vkaf167. Online ahead of print. ABSTRACT Since its approval in 2019, hypoxia-inducible factor (HIF) prolyl hydroxylase inhibitors, like roxadustat, have been used for treatment of anemia in chronic kidney disease. However, the impact of HIF stabilization on circulating leukocytes remains largely unexplored. In this study, we examined how clinically … Read more